Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Health Watch.
Press releases published on July 2, 2025
I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
Data show confirmed ORR of 83% (10/12) at doses selected for ongoing expansion study Median follow-up of 9.0 months as of the updated data cutoff Responses observed in patients with low PD-L1 and/or CLDN18.2 expression Company to host investor event on …
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma
TARRYTOWN, N.Y., July 02, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult patients …
Houston to host 2025 AAU Junior Olympic Games July 22 - August 2
Houston, TX, July 02, 2025 (GLOBE NEWSWIRE) -- The Amateur Athletic Union (AAU), in conjunction with the Harris County - Houston Sports Authority (HCHSA), will host the 2025 AAU Junior Olympic Games in five (5) different venues across the Greater Houston …
U.S. Oral Surgery Management Names Doug Drew CEO
IRVING, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) developed and implemented a succession plan earlier this year to ensure a smooth transition from long- time CEO, Richard Hall. Hall is transitioning from his role as …
Intuitive’s da Vinci 5 Surgical System Receives CE Mark
SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark …
Athelas Launches AIR: The Only EHR with Fully Integrated Ambient Scribing, AI Agents, and Hands-Free RCM Automation
MOUNTAIN VIEW, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Athelas, healthcare technology company powered by Commure, today announced the launch of Athelas AIR, its next-generation electronic health record (EHR) system designed to meet the needs of health …
Cyclacel Pharmaceuticals Announces Stock Split
BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a …
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to …
Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy
TAIPEI, Taiwan, July 02, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With total capital raised now exceeding …
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the recent U.S.-Poland Science and Technology …
The International Myeloma Foundation Proudly Announces EMA-CHMP Positive Qualification Advice to i2TEAMM Novel Biomarker Procedure Application on the Use of MRDnegCR as an Intermediate Early Endpoint for Conditional Market Approval in Myeloma Clinical…
STUDIO CITY, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the collaborative stakeholder group i2TEAMM (International Independent Team for Endpoint Approval of Myeloma MRD), which includes top global myeloma …
AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions
DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader in total healthcare talent solutions, today announced the sale of its Smart Square® scheduling software to symplr®, a leader in enterprise healthcare operations software. In …
Cronos Grows its International Footprint in Switzerland
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its …
Nuwellis Appoints John Erb as Chief Executive Officer
WHO WHAT WHERE WHEN HOW John Erb Appointed as Chief Executive Officer (no longer serving in an interim capacity) Nuwellis Headquarters Effective June 27, 2025 Appointment confirmed by the Board of Directors following his interim leadership MINNEAPOLIS, …
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS inFoods® IBS provides personalized identification of food …
Extendicare Acquires Closing the Gap Healthcare Group
MARKHAM, Ontario, July 02, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned home healthcare subsidiary, ParaMed Inc. (“ParaMed” or the “Purchaser”), completed the previously …
Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral
Pneumagen’s intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact, peer-reviewed Infectious Diseases and Therapy journal. St …
AppleGate Recovery Unveils Brand Refresh Aligned with BayMark Health Services Continuum of Care
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- AppleGate Recovery, a leading provider of office-based medication-assisted treatment (MAT) for substance use disorders, is proud to announce the launch of its refreshed brand identity. The update unifies …
Middlesex Recovery Unveils Brand Refresh to Reflect Unified Identity with BayMark Health Services
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Middlesex Recovery, a provider of office-based opioid treatment for substance use disorders, has introduced a brand refresh that reflects its alignment with BayMark Health Services and its family of …